Official Publication of Allelopathy Books
Online:
Clarivate Analytics Impact Factor : 0.962
OPEN ACCESS (1994-2021) Except present year
UGC Approved & Indexed in Web of Science, SCOPUS, BIOSIS
CURRENT IMPACT FACTOR : 0.962
Editor-in-Chief Prof. M. J. Reigosa, Spain
Published Bi-monthly with New Editorial Board
Faster Ms. Publication: 2-3 months after Submission
STEPS TO OPEN ACCESS (1994-2021)

1. Click on New Registration at Top Right Corner. 2. Fill your details and Click on Register. 3. After Registration Click on Login at Top Right Corner.
4. Fill your Email ID and password and click on Login. 5. Click on Abstract. 6. Click on View this paper to Download. If any problem contact us at Chiefeditor@allelopathyjournal.com , allelopathy2021@gmail.com , narwals2021@gmail.com

CORONA PANDEMIC 2020-2022
Since 2020, Corona Pandemic has almost stopped research in most countries. Thus, we received less Mss. during this period, hence, we have to reduce the Number of Mss. published in each Issue of Allelopathy Journal.
CALL FOR PAPERS : To overcome the adverse effects of Corona Pandemic on your Research Group. Please advise your contact/ Friend Researchers to submit their Research Papers to Allelopathy Journal for its survival.
NEW ISSN
Due to oversight, the National Science Library, New Delhi, India, informed us that for Allelopathy Journal Electronic Edition is assigned ISSN 0973-5046. However, Web Of Science (Clarivate Analytics) informed us that present ISSN used for Online Edition of allelopathy Journal is INCORRECT. Then we found that the correct ISSN for Electronic Edition of Allelopathy Journal is 0974-1240, however, the present ISSN 0971-4693/94 for Print Edition is Correct.
NEW MAIL ADDRESSES
The Inbox of our old mail addresses: allelopathy2017@gmail.com and narwals2017@gmail.com space became full. Hence, we have opened the following new mail addresses for future correspondence: info@allelopathyjournal.com, Chiefeditor@allelopathyjournal.com, allelopathy2021@gmail.com and narwals2021@gmail.com . Therefore in future please start corresponding at our these new Mail addresses.
Please wait ! while loading...